ErbB4 as a Potential Molecular Target in the Treatment of Esophageal Squamous Cell Cancers
ErbB4 is an important member of ErbB subfamily of tyrosine kinases receptor with overexpression in several tumors; however its biological role in esophageal cancer is poorly understood till date. The main objective of this study was to examine whether miRNA-140-5p could target and control ErbB4 expr...
Saved in:
Main Authors: | Ke Zhao, Bao-Jun Chen, Zhi-Guo Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/124105 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01) -
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
by: Fiona Reid, et al.
Published: (2023-06-01) -
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
by: Ji-Ji Dao, et al.
Published: (2025-01-01) -
Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis
by: Yuh-Shyan Tsai, et al.
Published: (2012-01-01) -
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01)